17,5 %17.5% of fevers were treated with an antimalarial drug within 48 hours at a health care facility in Kenya in 2002.
Kenyafeverobservé 2002publié 2006BMC public healtheurope_pmcdocument de 10 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 32 / 268
17,5 %17.5% of fevers were treated with an antimalarial drug within 48 hours at a health care facility in Kenya in 2002.
Kenyafeverobservé 2002publié 2006BMC public healtheurope_pmcdocument de 10 observations
0,26 incidence_rate_ratioAlpha+-thalassaemia is associated with a reduced incidence of severe nonmalaria anaemia, with an incidence rate ratio of 0.26 (95% CI: 0.09–0.77; p = 0.015) for heterozygotes and homozygotes combined compared to normal children.
Kenyaalpha+-thalassaemia · severe nonmalaria anaemiapublié 2006PLoS medicineeurope_pmcdocument de 2 observations
In the field study, immature and adult Anopheles mosquito populations were significantly lower in the intervention village compared to the control village during the larviciding period.
KenyaAnopheles · paludismeobservé larviciding periodpublié 2020Malaria journalPubMeddocument de 4 observations
28 %The 14-day secondary attack rate of SARS-CoV-2 among household contacts of PCR-confirmed cases in rural Kenya was 28%.
KenyaCOVID-19observé October 2020 to September 2022publié 2023Symptom prevalence and Secondary Attack Rate of SARS-CoV-2 in Rural Kenyan Households: a peurope_pmcdocument de 3 observationsDOI 10.22541/au.168068165.55407669/v1
53 %Among Kenyan adolescents aged 15–19 years in Kisumu with no prior PrEP use, 53% were willing to consider using PrEP.
KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 15 observations
There were no re-infections observed during the stated 28-day follow-up period.
Kenyapaludismeobservé 2015publié 2021Epidemiology and infectionPubMeddocument de 5 observations
53 %Among pharmacy PrEP clients in Kenya, 53% (151/287) reported multiple sexual partners in the past 6 months.
KenyaVIH/sidapublié 2023Journal of the International AIDS Societyeurope_pmcdocument de 12 observationsDOI 10.1002/jia2.26131
7,8 %7.8% (53/683) of tested mosquito abdomens were positive for Plasmodium falciparum.
Kenyapaludismepublié 2024Parasites & vectorsPubMeddocument de 5 observations
33,3 %Cluster 1 of anaemia among school-aged children in western Kenya had a prevalence of 33.3% at villages.
Kenyaanémieobservé February 2022publié 2023PloS oneeurope_pmcdocument de 5 observationsDOI 10.1371/journal.pone.0282382
200 cells/μlNadir CD4 T-cell count 200 cells/μl or less was associated with elevated soluble CD14 among people living with HIV.
KenyaVIH/sidapublié 2021AIDS (London, England)PubMeddocument de 9 observations
3,7 %Among the 352 symptomatic participants who were tested for HIV, 13 tested positive, corresponding to a positivity rate of 3.7%.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 7 observations
31,1 hoursIn scenario 3, the average turnaround time (TAT) for HIV viral load monitoring decreased to 31.1 hours.
KenyaVIH/sidapublié 2024Health policy and planningPubMeddocument de 15 observations
3 000 000 000 peopleMore than 3 billion people were at risk of malaria in 2005.
Kenyapaludismeobservé 2005publié 2006Advances in parasitologyeurope_pmcDOI 10.1016/s0065-308x(05)62005-2
25 %Adolescent girls and young women account for 25% of annual HIV incidence among people older than 15 years in Kenya.
KenyaVIH/sidapublié 2025JMIR research protocolsPubMeddocument de 4 observations
1 596 infantsAmong 2020 HIV-exposed infants (HEI), 1596 had their first HIV PCR within 2 months of birth.
KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 11 observations
21,9 %Of 14,227 women screened using self-sampling for HPV DNA testing, 3111 (21.9%) were HPV positive.
Kenyainfection à HPVpublié 2026BMC cancerPubMeddocument de 12 observations
59,9 %Among women with gestational diabetes in Nyeri County, Kenya, 59.9% delivered via caesarean delivery.
Kenyadiabète gestationnelpublié 2022The Pan African medical journalPubMeddocument de 3 observations
20,6 %Among 2796 reviewed COVID-19 case records in Kenya, 2340 contacts were listed for 577 (20.6%) cases.
KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations
27,38 %High grade squamous intraepithelial lesion (HSIL) was highest among HPV/HIV co-infected women with a prevalence of 23 (27.38%).
Kenyahigh grade squamous intraepithelial lesion · HPV/HIV co-infectionpublié 2020The Pan African medical journalPubMeddocument de 5 observations
The 90-90-90 UNAIDS indicators were 93%-97%-95% in Ndhiwa sub-county in 2018.
KenyaVIH/sidaobservé 2018publié 2021Tropical medicine & international health : TM & IHPubMeddocument de 7 observations
52,1 %Of the 135 HPV-positive women who were notified of their results, 73 (52.1%) received cryotherapy.
Kenyainfection à HPVobservé 2018publié 2021International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 7 observations
7 %The prevalence of family history of breast cancer as a breast cancer risk factor was 7.0% among the studied women.
Kenyacancer du seinobservé 2019 and 2020publié 2026JCO global oncologyPubMeddocument de 10 observations
49 %Among children aged 3-59 months who received malaria chemoprophylaxis from a village health worker in addition to treatment, there was a 49% reduction in mortality.
Kenyapaludismepublié 1990Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 2 observations
31 %Malaria test positivity rate (TPR) among febrile admissions aged 1 month to 14 years at Tororo district hospital was 31% during the final period of Actellic IRS and LLIN (June 2016–December 2019).
Kenyapaludismeobservé June 2016–December 2019publié 2020Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/s12936-020-03490-4
9,7 %Of 62 women with false positive rapid HIV results, 6 (9.7%) had dually positive rapid test results.
KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.